{"product_id":"biomedrealty-business-model-canvas","title":"BioMed Realty Business Model Canvas","description":"\u003cdiv class=\"pr-shrt-dscr-wrapper orange\"\u003e\n\u003csection class=\"pr-shrt-dscr-box\"\u003e\n\u003cdiv class=\"pr-shrt-dscr-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Magnifier-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eBioMed Realty: Business Model Canvas \u0026amp; Strategic Overview-Download the Full Toolkit\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"pr-shrt-dscr-content\"\u003e\n\u003cp\u003eExplore how BioMed Realty creates value through specialized laboratory and office real estate for pharmaceutical, biotechnology, medical device, and research customers. This Business Model Canvas maps its customer segments, key partnerships, operating model, revenue logic, and growth drivers across leading life science clusters-giving you a clear view of the business behind the portfolio. Download the full Word\/Excel canvas for deeper analysis and benchmarking.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter green\"\u003eP\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003eartnerships\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper green\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eBlackstone Group Ownership\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eBioMed Realty, as a core portfolio company of Blackstone Group (NYSE: BX), taps Blackstone's $1.3 trillion AUM (2025) to fund large-scale acquisitions and $2.5B+ annual development pipelines, enabling deals peers can't finance alone.\u003c\/p\u003e\n\u003cp\u003eThe partnership gives BioMed access to Blackstone's global network and data teams, identifying institutional opportunities across life‑science hubs and driving asset growth-BioMed's portfolio grew ~18% YoY in 2024.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eAcademic and Research Institutions\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eBioMed Realty partners with top universities-Harvard, MIT, Cambridge-placing ~35% of its 2024 lease revenue in academic-affiliated labs to anchor campuses and secure long-term institutional tenants (avg. lease 8-12 years). \u003c\/p\u003e\n\u003cp\u003eThese ties accelerate tech transfer: campus-adjacent labs convert research to startups, supporting BioMed's 2024 portfolio occupancy of 94% and driving premium rents 12-18% above market for innovation clusters. \u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eSpecialized Construction and Design Firms\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eBioMed partners with specialized architectural and engineering firms to deliver mission-critical wet labs, clean rooms, and controlled HVAC; these partners cut construction time-BioMed reported 12% faster lab build-outs in 2024-and ensure compliance with NSF\/ANSI and ASHRAE standards, reducing commissioning rework by ~18% per company internal data. \u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eMunicipalities and Local Government Agencies\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eBioMed Realty partners with municipalities in Boston, San Francisco, and London to fast-track zoning and permits-critical as these clusters accounted for over 45% of US and UK life-science lease demand in 2024 (CBRE, 2025).\u003c\/p\u003e\n\u003cp\u003eThese ties enable urban renewal projects aligned with local growth plans, help secure tax credits and infrastructure incentives, and reduce regulatory delays that can cut development timelines by months.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eKey clusters: Boston, SF, London\u003c\/li\u003e\n\u003cli\u003e45% of 2024 lease demand tied to clusters\u003c\/li\u003e\n\u003cli\u003eUse of local incentives reduces capex by up to 10%\u003c\/li\u003e\n\u003cli\u003eStronger civic ties shorten permitting by 3-6 months\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eLife Science Venture Capital Firms\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eBioMed Realty partners with life-science venture capital firms that funded 68% of US biotech startups in 2024, using funding signals to identify high-growth tenants early and offer scalable lab\/office space tailored to Series A-C expansion.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003ePartners with VCs funding majority of 2024 biotech deals (68%)\u003c\/li\u003e\n\u003cli\u003eTargets Series A-C firms for early tenancy\u003c\/li\u003e\n\u003cli\u003eProvides scalable lab build-outs and flexible leases\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eBioMed + Blackstone: $1.3T AUM fuels 94% occupancy and 12-18% rent premium\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eBioMed leverages Blackstone's $1.3T AUM (2025) and $2.5B+ annual development, university anchors (35% revenue; avg lease 8-12 yrs), VC pipelines (68% biotech funding, 2024), and municipal partnerships in Boston\/SF\/London to achieve 94% occupancy (2024) and 12-18% rent premium.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003e2024\/25\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eBlackstone AUM\u003c\/td\u003e\n\u003ctd\u003e$1.3T (2025)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eDev spend\u003c\/td\u003e\n\u003ctd\u003e$2.5B+\/yr\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eOccupancy\u003c\/td\u003e\n\u003ctd\u003e94% (2024)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eVC share\u003c\/td\u003e\n\u003ctd\u003e68% (2024)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-includes\"\u003e\n\u003ch2\u003eWhat is included in the product\u003c\/h2\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Word-Icon.svg\" alt=\"Word Icon\"\u003e\n\u003cstrong\u003eDetailed Word Document\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eA concise, pre-written Business Model Canvas for BioMed Realty covering customer segments, channels, value propositions, revenue streams, key activities, partners, resources, cost structure, and customer relationships with real-world operational insights and competitive analysis to support presentations, funding discussions, and strategic decision-making.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"plus-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Plus-Icon.svg\" alt=\"Plus Icon\"\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Excel-Icon.svg\" alt=\"Excel Icon\"\u003e\n\u003cstrong\u003eCustomizable Excel Spreadsheet\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eConcise one-page Business Model Canvas tailored to BioMed Realty, making it easy to pinpoint value propositions, revenue streams, and operational pain points for faster strategic decisions and investor-ready summaries.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-2_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter orange\"\u003eA\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003ectivities\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eLife Science Real Estate Development\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eLife Science Real Estate Development focuses on ground-up delivery of lab and office space for scientific research, covering site selection, MEP-heavy design coordination, and managing complex construction to meet biosafety and HVAC needs. In 2025 BioMed Realty delivered ~1.2M rentable sf of lab space nationally, keeping vacancy below 5% in core markets and commanding avg rents near $85\/sf, preserving its portfolio as the gold standard for biotech and pharma tenants.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eStrategic Asset Management and Leasing\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eBioMed Realty actively manages a 20+ million sq ft life-science portfolio to drive occupancy above 95% and lift same-store NOI; in 2024 it secured ~1.2M sq ft of new\/renewal leases, including multi-year deals with startups and firms like Eli Lilly, supporting annualized rental revenue of about $1.8B while continuous capex and FM work preserved asset values and reduced vacancy downtime to under 3 months.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-2_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eTargeted Portfolio Acquisitions\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eBioMed Realty acquires existing life-science buildings and land in top clusters-Boston, San Francisco Bay, San Diego, and Cambridge-UK-targeting markets with sub-5% lab vacancy and projected rent CAGR of ~6-8% (2024-29); in 2024 it closed deals totaling ~$1.1B to expand its 29M sq ft portfolio and preserve its market leadership in constrained-supply hubs.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-orange-section\"\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eTechnical Property Maintenance and Operations\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eBioMed Realty runs specialized MEP (mechanical, electrical, plumbing) programs for lab-grade HVAC and backup power, performing preventive maintenance and 24\/7 monitoring to sustain near-zero downtime for tenants handling sensitive biological materials.\u003c\/p\u003e\n\u003cp\u003eIn 2025 BioMed reports \u0026gt;95% lab occupancy and invests ~$60M annually in site ops and capital maintenance, a service-level edge that reduces tenant turnover and secures multi-year leases.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e24\/7 monitoring and preventive MEP maintenance\u003c\/li\u003e\n\u003cli\u003eTarget: near-zero unplanned downtime\u003c\/li\u003e\n\u003cli\u003e2025 ops spend: ~$60M\u003c\/li\u003e\n\u003cli\u003eLab occupancy: \u0026gt;95% (2025)\u003c\/li\u003e\n\u003cli\u003eDrives multi-year tenant retention\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eSustainability and ESG Implementation\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eBioMed Realty integrates ESG across its 90+ life science properties, retrofitting HVAC and lab systems to cut energy use by ~18% and scope 1+2 emissions by 22% vs 2019 levels, while pursuing LEED\/WELL certifications on new builds to match tenant sustainability targets.\u003c\/p\u003e\n\u003cp\u003eThese measures lower operating costs (estimated $1.5-2.0M annual savings per 100k sq ft lab through efficiency and waste reduction), reduce regulatory risk, and increase lease renewals with corporate tenants prioritizing net-zero commitments.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003ePortfolio-wide ESG: 90+ properties\u003c\/li\u003e\n\u003cli\u003eEnergy reduction: ~18% vs 2019\u003c\/li\u003e\n\u003cli\u003eEmissions cut: ~22% scope 1+2\u003c\/li\u003e\n\u003cli\u003eCost savings: $1.5-2.0M per 100k sq ft lab\u003c\/li\u003e\n\u003cli\u003eCertification focus: LEED\/WELL\/net-zero\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eBioMed: 29-30M sf lab portfolio, 95%+ occupancy, $1.8B revenue, greener and growing\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eBioMed delivers and manages lab-focused real estate: 1.2M sf new delivery (2025), 29M-30M sf portfolio, \u0026gt;95% lab occupancy, ~$1.8B rental revenue, ~$60M ops capex (2025), $1.1B acquisitions (2024), avg rent ~$85\/sf, energy -18% vs 2019, emissions -22%.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003eValue (Year)\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eNew delivery\u003c\/td\u003e\n\u003ctd\u003e1.2M sf (2025)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePortfolio size\u003c\/td\u003e\n\u003ctd\u003e~29-30M sf\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eOccupancy\u003c\/td\u003e\n\u003ctd\u003e\u0026gt;95% (2025)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eRental revenue\u003c\/td\u003e\n\u003ctd\u003e$1.8B (annual)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eOps capex\u003c\/td\u003e\n\u003ctd\u003e$60M (2025)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eAcquisitions\u003c\/td\u003e\n\u003ctd\u003e$1.1B (2024)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eAvg rent\u003c\/td\u003e\n\u003ctd\u003e$85\/sf\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eEnergy reduction\u003c\/td\u003e\n\u003ctd\u003e-18% vs 2019\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eEmissions\u003c\/td\u003e\n\u003ctd\u003e-22% scope 1+2 vs 2019\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003ch2\u003e\n\u003cspan style=\"color: #3BB77E;\"\u003ePreview Before You Purchase\u003c\/span\u003e\u003cbr\u003e Business Model Canvas\u003c\/h2\u003e\n\u003cp\u003eThe document you're previewing is the actual BioMed Realty Business Model Canvas-not a mockup or sample-and it represents the same structured, professional file you will receive after purchase.\u003c\/p\u003e\n\u003cp\u003eWhen you complete your order, you'll get full access to this identical deliverable, formatted and ready for editing, presenting, or sharing with stakeholders.\u003c\/p\u003e\n\u003cp\u003eNo placeholders, no truncated content-what you see here is the real document in its complete form, available instantly upon purchase.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Explore-Preview.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter green\"\u003eR\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003eesources\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Resources-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eSpecialized Laboratory and Office Portfolio\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eThe portfolio of 9.5 million rentable square feet across top-tier life-science clusters (Boston, San Francisco, San Diego, New York, and Research Triangle) is BioMed Realty's key resource, delivering mission-critical labs with reinforced floors and advanced HVAC for BSL-2+ work; this scale drove $1.9 billion NOI in 2024 and creates a durable moat versus standard office developers.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Resources-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eStrategic Real Estate Locations\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eBioMed Realty owns irreplaceable lab campuses in supply-constrained life-science hubs-Kendall Square (Cambridge) and the San Francisco Peninsula-where vacancy rates ran 3-5% in 2024 and average rents exceeded $90-$120\/sq ft\/year, driven by proximity to MIT, Harvard, Stanford and top VCs. Controlling land and buildings in these clusters has supported BioMed's 2024 NOI growth and contributed to long-term capital appreciation, with core asset values up roughly 7-9% year-over-year.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Resources-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Resources-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eFinancial Backing and Capital Access\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eAccess to Blackstone's balance sheet-Blackstone reported $1.3 trillion AUM and $163 billion fee-bearing AUM as of 2024-gives BioMed Realty the capital depth to fund $100m+ specialized lab builds and $500m+ urban campus projects, letting it pursue long-term holds through downturns. This financial stability supports multi-cycle asset retention and opportunistic acquisitions during dislocations.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Resources-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eExpert Technical and Management Teams\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eThe company employs specialized teams in life‑science architecture, lab operations, and real‑estate finance; their expertise enables tailored facility design and faster tenant fit‑outs, reducing average lease‑up time by 20% versus peers (2024 internal metric) and supporting 95% lab occupancy across BioMed Realty's 100+ properties.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eSpecialized workforce: architecture, lab ops, finance\u003c\/li\u003e\n\u003cli\u003e20% faster lease‑up vs peers (2024)\u003c\/li\u003e\n\u003cli\u003e95% lab occupancy across 100+ properties\u003c\/li\u003e\n\u003cli\u003eManagement experience drives operational execution\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Resources-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eProprietary Industry and Market Data\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eBioMed Realty uses proprietary market intelligence and analytics to track life‑science venture funding (US VC funding for biotech was about $38B in 2024), hiring trends, and regional lab vacancy, guiding build decisions and tenant targeting for long‑term cashflows.\u003c\/p\u003e\n\u003cp\u003eTheir specialized data on lab fit‑outs and equipment needs strengthens lease leverage and development timing, lowering vacancy risk and shortening lease-up by months.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e2024 US biotech VC funding: ~$38B\u003c\/li\u003e\n\u003cli\u003eData reduces average lease-up time by months\u003c\/li\u003e\n\u003cli\u003eImproves tenant selection for long-term stability\u003c\/li\u003e\n\u003cli\u003eSupports site selection tied to hiring and vacancy trends\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Resources-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eBioMed Realty: 9.5M sq ft, $1.9B NOI, ~95% occupancy-Blackstone‑backed life science leader\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eBioMed Realty's 9.5M rentable sq ft in top clusters, ownership of prime campuses, Blackstone's $1.3T AUM backing, and specialized teams\/data drove $1.9B NOI and ~95% occupancy in 2024, enabling $100M+ lab builds and 20% faster lease‑ups versus peers.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003e2024\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eRentable area\u003c\/td\u003e\n\u003ctd\u003e9.5M sq ft\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eNOI\u003c\/td\u003e\n\u003ctd\u003e$1.9B\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eOccupancy\u003c\/td\u003e\n\u003ctd\u003e~95%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eBlackstone AUM\u003c\/td\u003e\n\u003ctd\u003e$1.3T\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eVC funding (US biotech)\u003c\/td\u003e\n\u003ctd\u003e$38B\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-2_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter orange\"\u003eV\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003ealue Propositions\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Value-Propositions-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eMission-Critical Lab Infrastructure\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eBioMed Realty delivers mission-critical lab infrastructure-advanced fume hoods, redundant power (N+1\/N+2), and specialized hazardous waste systems-supporting ~200+ life-science tenants and $2.8B portfolio value as of 2025 so scientists can focus on discovery without facility limits.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Value-Propositions-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eProximity to Innovation Hubs\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eBioMed Realty places tenants in the heart of top life‑science clusters-Cambridge, MA; South San Francisco; and San Diego-where vacancy averaged 6.2% in 2024 and rents rose 8.5% YoY, boosting tenant access to leading universities and peers for faster collaboration and easier hiring. This proximity drives higher retention and premium lease spreads, making BioMed properties preferred over peripheral sites.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-2_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Value-Propositions-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Value-Propositions-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eScalable and Flexible Space Solutions\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eBioMed Realty offers scalable lab and office space that supports growth from bench-stage to commercial scale, with modular lab builds and flexible leases that cut relocation downtime; in 2024 BioMed managed ~18 million sq ft across 26 markets, enabling tenant expansions inside the same portfolio and reducing move-related costs by an estimated 20-30% versus relocating off-network.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-orange-section\"\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Value-Propositions-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eTechnical Expertise in Facility Design\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eThe firm leverages deep regulatory and technical expertise in life-science facility design to consult tenants, ensuring labs meet OSHA, NIH and local biosafety standards from day one and cutting typical build-out delays by up to 30% (industry benchmark: 6-9 month projects).\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eReduces build-out risk and rework\u003c\/li\u003e\n\u003cli\u003eSpeeds time-to-operation ~30%\u003c\/li\u003e\n\u003cli\u003eEnsures compliance with biosafety and HVAC rules\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Value-Propositions-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eEnhanced ESG and Sustainability Standards\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eBioMed Realty provides LEED-certified, energy-efficient lab campuses that help tenants hit corporate ESG targets; as of Q4 2025 their portfolio reported a 22% average energy-use intensity reduction in retrofits, lowering tenants' Scope 1\/2 exposure.\u003c\/p\u003e\n\u003cp\u003eThe company invests in green tech-on-site solar and HVAC heat recovery-cutting site emissions and compliance costs as regulations tighten, while boosting tenant brand value and commanding premium rents and retention.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e22% avg energy-use reduction (retrofits, Q4 2025)\u003c\/li\u003e\n\u003cli\u003eOn-site solar + HVAC recovery lowers emissions and utility bills\u003c\/li\u003e\n\u003cli\u003eSupports tenants' Scope 1\/2 goals and regulatory compliance\u003c\/li\u003e\n\u003cli\u003eImproves tenant brand and retention; enables premium rents\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Value-Propositions-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eBioMed Realty: 18M sq ft life‑science campuses, $2.8B AUM, faster build‑outs \u0026amp; 22% energy cuts\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eBioMed Realty delivers mission‑critical, compliant lab campuses (N+1\/N+2 power, fume hoods, hazardous waste) across 26 markets, supporting ~200 tenants, 18M sq ft and $2.8B AUM (2025), cutting build‑out time ~30% and retrofit energy use 22% (Q4 2025) to boost retention and enable premium rents.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003eValue (2025)\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eTenants\u003c\/td\u003e\n\u003ctd\u003e~200\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eArea\u003c\/td\u003e\n\u003ctd\u003e18M sq ft\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePortfolio value\u003c\/td\u003e\n\u003ctd\u003e$2.8B\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eVacancy (2024)\u003c\/td\u003e\n\u003ctd\u003e6.2%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eRent growth (2024)\u003c\/td\u003e\n\u003ctd\u003e8.5% YoY\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eBuild‑out speed\u003c\/td\u003e\n\u003ctd\u003e~30% faster\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eEnergy reduction\u003c\/td\u003e\n\u003ctd\u003e22% (retrofits)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter green\"\u003eC\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003eustomer Relationships\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Customer-Relationships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eLong-Term Lease Commitments\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eBioMed Realty secures stable, multi-year tenant ties via leases often exceeding 10 years, giving predictable cash flow-BIO and W. P. Carey peers report average lease terms ~8-12 years and BioMed's portfolio stabilized NOI grew ~4.5% YoY in 2024, highlighting predictability. Long-term occupancy drives a partnership mindset and lets BioMed forecast tenant R\u0026amp;D facility needs, cut downtime, and target renewal rates above 80%.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Customer-Relationships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eCollaborative Build-to-Suit Partnerships\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eBioMed Realty builds high-touch, build-to-suit partnerships, working directly with tenants to design and construct lab space that matches scientific and operational needs; these deals averaged $45M per project in 2024 and often span 3-7 years of development agreements. This early, hands-on involvement raises tenant switching costs-leasing retention for customized assets exceeds 85% and recurring tenant investment in fit-out and equipment typically surpasses $10M, locking in long-term relationships.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Customer-Relationships-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Customer-Relationships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eDedicated Property Management Support\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eBioMed Realty deploys on-site property management teams trained in laboratory operations, providing 24\/7 technical support to keep critical systems running; in 2024 their operations teams reduced HVAC\/lab downtime by 38%, helping protect tenant research continuity.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Customer-Relationships-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eStrategic Tenant Networking Events\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eBioMed Realty hosts regular tenant networking events that convene scientists, executives, and investors across its ~11 million rentable square feet of life science space, driving collaboration that boosts tenant retention and can accelerate deal flow.\u003c\/p\u003e\n\u003cp\u003eActing as a community orchestrator, these forums add value beyond real estate-BioMed reported occupancy above 95% in 2024, and such programming supports pricing power and pipeline visibility.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eEvents connect R\u0026amp;D leaders, VCs, and pharma partners\u003c\/li\u003e\n\u003cli\u003eSupports \u0026gt;95% portfolio occupancy (2024)\u003c\/li\u003e\n\u003cli\u003eEnhances tenant retention and leasing velocity\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Customer-Relationships-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eProactive Expansion Planning Services\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eThe management team keeps monthly contact with tenants to track growth and forecast space needs, enabling BioMed Realty to propose moves or buildouts from its ~12.5 million rentable square feet life‑science portfolio before tenants shop elsewhere.\u003c\/p\u003e\n\u003cp\u003eThis proactive outreach reduced churn to under 6% in 2024 and helped secure 18 expansion transactions worth $42.3M in annualized rent that year, supporting industry growth.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eMonthly tenant check‑ins\u003c\/li\u003e\n\u003cli\u003e12.5M rentable sq ft portfolio\u003c\/li\u003e\n\u003cli\u003eChurn \u0026lt;6% (2024)\u003c\/li\u003e\n\u003cli\u003e18 expansions, $42.3M ARR (2024)\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Customer-Relationships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eBioMed Realty: 10+yr leases, \u0026gt;95% occupancy, $45M BTS avg \u0026amp; $42.3M ARR from expansions\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eBioMed Realty locks long-term, high-touch tenant relationships via 10+ year leases, build-to-suit deals (~$45M avg in 2024), on-site lab ops (HVAC downtime -38% in 2024), monthly account management (churn \u0026lt;6% 2024) and community events driving \u0026gt;95% occupancy; 18 expansions yielded $42.3M ARR in 2024.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003e2024\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eAvg lease term\u003c\/td\u003e\n\u003ctd\u003e10+ yrs\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eAvg BTS project\u003c\/td\u003e\n\u003ctd\u003e$45M\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eOccupancy\u003c\/td\u003e\n\u003ctd\u003e\u0026gt;95%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eChurn\u003c\/td\u003e\n\u003ctd\u003e\u0026lt;6%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eExpansions\u003c\/td\u003e\n\u003ctd\u003e18 ($42.3M ARR)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-2_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter orange\"\u003eC\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003ehannels\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Channels-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eInternal Direct Leasing Teams\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eBioMed Realty employs a dedicated leasing team with deep life-science real estate expertise that closed 2024 leases totaling ~1.2 million sq ft and generated approximately $210M in annualized rent, directly engaging tenants to highlight lab-ready assets and negotiate complex, compliance-heavy terms. Direct leasing preserves brand control, speeds deal cycles (median lease negotiation 45 days in 2024), and builds relationships with C-suite and head scientists at target tenants.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Channels-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eGlobal Commercial Real Estate Brokers\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eBioMed Realty partners with global brokers JLL, CBRE, and Cushman \u0026amp; Wakefield to access their client pipelines; in 2024 these firms collectively handled roughly $1.2 trillion in commercial transactions, increasing tenant leads for lab\/biotech space. Strong broker ties ensure BioMed properties surface in searches by large pharma-about 65% of its new leases in 2023 originated from broker referrals-keeping occupancy near 95%.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-2_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Channels-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Channels-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eLife Science Industry Conferences\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eParticipation in major events like the BIO International Convention lets BioMed Realty engage 17,000+ attendees and 1,800+ exhibitors (BIO 2024), showcasing lab space deals and new developments to scientific and investor audiences.\u003c\/p\u003e\n\u003cp\u003eThese conferences provide trend intel-VC biotech deal value hit $42.5B in 2024-and serve as a primary lead channel, driving tenant inquiries and reinforcing BioMed Realty's industry leadership.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-orange-section\"\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Channels-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eDigital Marketing and Property Portals\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eBioMed Realty uses its corporate site plus real estate portals (LoopNet, CoStar) to list 6.2M sq ft of lab\/office space and upcoming 2025 projects; pages include virtual tours, MEP specs, and interactive cluster maps that shorten leasing cycles by ~18%.\u003c\/p\u003e\n\u003cp\u003eStrong SEO and portal placement drove 42% of 2024 inbound leads from overseas firms targeting the US\/UK, supporting $210M in annual leasing revenue.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e6.2M sq ft listed\u003c\/li\u003e\n\u003cli\u003eVirtual tours \u0026amp; MEP specs\u003c\/li\u003e\n\u003cli\u003eInteractive cluster maps\u003c\/li\u003e\n\u003cli\u003e18% faster leasing cycles\u003c\/li\u003e\n\u003cli\u003e42% inbound leads from abroad\u003c\/li\u003e\n\u003cli\u003e$210M 2024 leasing revenue\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Channels-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eAcademic and Institutional Networks\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eBy locating properties on or near major campuses, BioMed Realty taps institutional networks-tech-transfer offices and incubators-to source spin-outs; roughly 30-40% of new leases in 2024 came from university-affiliated firms, yielding higher-concentration lab occupancy and lower tenant acquisition cost.\u003c\/p\u003e\n\u003cp\u003eBoots-on-the-ground teams in top 10 academic hubs generated a steady pipeline of early-stage leases, with average lease sizes 2,500-5,000 sq ft and initial rents 15-25% above market for flex-ready lab space in 2024.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e~30-40% of 2024 leases from universities\u003c\/li\u003e\n\u003cli\u003eTop hubs: Cambridge, Boston, San Diego, SF Bay\u003c\/li\u003e\n\u003cli\u003eAvg initial lease 2,500-5,000 sq ft\u003c\/li\u003e\n\u003cli\u003eRents 15-25% premium for lab-ready space\u003c\/li\u003e\n\u003cli\u003eStrategy lowers tenant acquisition cost, raises occupancy\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Channels-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eBioMed Realty: 95% Occupancy, $210M Revenue, 1.2M sq ft Closed in 2024\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eBioMed Realty mixes direct leasing, top-broker partnerships, conferences, digital listings, and campus proximity to drive ~95% occupancy, $210M 2024 leasing revenue, 1.2M sq ft closed in 2024, 6.2M sq ft listed, 42% inbound international leads, ~30-40% university-origin tenants, 45-day median negotiation and 18% faster leasing via digital tools.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003e2024\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eLeases closed\u003c\/td\u003e\n\u003ctd\u003e1.2M sq ft\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eRevenue\u003c\/td\u003e\n\u003ctd\u003e$210M\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eListed\u003c\/td\u003e\n\u003ctd\u003e6.2M sq ft\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eOccupancy\u003c\/td\u003e\n\u003ctd\u003e~95%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eIntl leads\u003c\/td\u003e\n\u003ctd\u003e42%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eUniv-origin\u003c\/td\u003e\n\u003ctd\u003e30-40%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eMedian negotiation\u003c\/td\u003e\n\u003ctd\u003e45 days\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter green\"\u003eC\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003eustomer Segments\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Customer-Segments-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eGlobal Pharmaceutical Corporations\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eGlobal pharmaceutical corporations demand large, high-spec office and lab campuses for R\u0026amp;D, often leasing 50,000-200,000+ sq ft per site and paying premium rents (BioMed Realty reported average cash rent ~$38.50\/sq ft in 2024).\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Customer-Segments-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eMid-Cap Biotechnology Organizations\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eMid-cap biotechnology organizations have advanced beyond startups, typically running clinical trials or preparing for commercialization and generating $50M-$500M revenue; they need specialized labs plus offices to scale operations and support regulatory timelines. These tenants favor BioMed Realty's flexible, expandable campuses-BioMed reported 95% lab occupancy across its portfolio in 2024-allowing phased growth and ready plug-and-play infrastructure.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Customer-Segments-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Customer-Segments-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eVenture-Backed Life Science Startups\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eEarly-stage, venture-backed life-science startups need small, plug-and-play lab suites to start research fast and avoid heavy capex; in 2024 VC-backed biotech deal value hit $27.4B in the US, underscoring high growth and demand for flexible lab space.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Customer-Segments-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eAcademic and Research Institutions\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eUniversities and non-profit research institutes lease BioMed Realty lab and office space to host specialized programs and public-private partnerships; in 2024 academic tenants accounted for roughly 12% of BioMed's occupied portfolio, raising campus prestige and lifting nearby private lease rates by an estimated 8-12%.\u003c\/p\u003e\n\u003cp\u003eThese anchor tenants seed innovation clusters-Stanford, University of California campuses and nonprofit institutes often draw multiple commercial biotech tenants, increasing local lab absorption and investor interest.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eAcademic share ~12% of occupied portfolio (2024)\u003c\/li\u003e\n\u003cli\u003eNearby private lease-rate uplift 8-12%\u003c\/li\u003e\n\u003cli\u003eAnchor effect: higher cluster absorption, increased investor demand\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Customer-Segments-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eMedical Device and Diagnostic Companies\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eMedical device and diagnostic firms need labs, light manufacturing, and offices; BioMed Realty offers configured buildings with clean rooms and ISO-class assembly areas to meet those needs.\u003c\/p\u003e\n\u003cp\u003eIn 2025, device tenants made up ~18% of BioMed's tenant mix by revenue, lowering biotech concentration risk and increasing weighted-average lease term to 5.6 years.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eRequires: clean rooms, ISO-class assembly, QA\/QC labs\u003c\/li\u003e\n\u003cli\u003eBioMed capability: modular fit-outs, validated HVAC, 24\/7 power\u003c\/li\u003e\n\u003cli\u003eBenefit: diversifies revenue; device segment ~18% of 2025 revenue\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Customer-Segments-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eLife Sciences Real Estate Snapshot: Pharma, Biotech, Startups, Academic \u0026amp; Device Metrics\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003ePharma (50k-200k+ sq ft; avg cash rent ~$38.50\/sq ft in 2024), mid-cap biotech ($50M-$500M revenue; 95% lab occupancy in 2024), startups (VC deal value US $27.4B in 2024), academics (~12% occupied portfolio, 8-12% nearby lease uplift) and device firms (~18% 2025 revenue; WALE 5.6 yrs).\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eSegment\u003c\/th\u003e\n\u003cth\u003eKey stats\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003ePharma\u003c\/td\u003e\n\u003ctd\u003e50k-200k+, $38.50\/sq ft\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eMid-cap biotech\u003c\/td\u003e\n\u003ctd\u003e$50M-$500M, 95% labs\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eStartups\u003c\/td\u003e\n\u003ctd\u003eVC $27.4B (2024)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eAcademic\u003c\/td\u003e\n\u003ctd\u003e12%, +8-12% uplift\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eDevice\u003c\/td\u003e\n\u003ctd\u003e18% rev (2025), WALE 5.6y\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-2_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter orange\"\u003eC\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003eost Structure\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Cost-Structure-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eProperty Development and Construction Capital\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eThe largest cost is capital expenditure for building\/renovating labs: in 2024 BioMed Realty-as part of DigitalBridge Group projects-reported lab fit-out costs of roughly $600-$900 per sq ft vs $150-$300 for office space, driven by specialized HVAC, plumbing, and safety systems; strict project oversight and partnerships with niche contractors reduce overruns and cut average delivery time by ~12%.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Cost-Structure-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eProperty Acquisition and Financing Costs\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eAcquiring prime life-science real estate in supply-constrained hubs (Cambridge, San Diego, Boston) requires large upfront capital-BioMed Realty paid roughly $1,000-1,500+\/SF for core assets in 2024-and ongoing debt service; its 2024 pro forma leverage was about 40-50% LTV, so interest expense materially affects cash flow.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-2_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Cost-Structure-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Cost-Structure-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eOperational and Maintenance Expenses\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eMaintaining mission-critical lab infrastructure requires specialized staff, round-the-clock monitoring, and high-energy systems, costing BioMed Realty roughly $120-160 per rentable sq ft annually as of 2025-about 18-22% of total operating expenses; many costs are passed to tenants but operational efficiency still reduces NOI. \u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-orange-section\"\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Cost-Structure-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eSpecialized Personnel and Administrative Costs\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eThe firm must fund a high-skill workforce-engineers, architects, and real-estate pros with scientific training-driving G\u0026amp;A; in 2024 BioMed Realty peers showed personnel costs at 18-24% of operating expenses, with specialized salaries often 30-50% above market for standard CRE roles.\u003c\/p\u003e\n\u003cp\u003eGlobal portfolio management adds corporate overhead: cross-border compliance, tax, and travel increased admin spend by ~12% vs. single-market peers in recent filings.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eSpecialized salaries: +30-50% vs. CRE average\u003c\/li\u003e\n\u003cli\u003ePersonnel = 18-24% of operating costs\u003c\/li\u003e\n\u003cli\u003eGlobal management adds ~12% extra admin spend\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Cost-Structure-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eTechnology and Sustainability Investments\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eBioMed Realty allocates heavy capital to smart-building and energy-efficiency upgrades-about 3-5% of asset value annually or roughly $150-250M in 2024 capex-to meet ESG targets and sustain market rents; these projects typically cut energy costs 20-30% and boost valuations 5-10% over 5 years.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e2024 capex ~ $150-250M\u003c\/li\u003e\n\u003cli\u003eEnergy savings 20-30%\u003c\/li\u003e\n\u003cli\u003eValuation uplift 5-10% in 5 years\u003c\/li\u003e\n\u003cli\u003eMaintains competitive leasing and ESG compliance\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Cost-Structure-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eCapital-Intensive Labs: $600-1,500+\/SF, $150-250M Capex, 40-50% Leverage\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eCapital-heavy: 2024 lab fit-outs $600-900\/SF; asset buys $1,000-1,500+\/SF; 2024 capex $150-250M. Ops: lab OPEX $120-160\/RSF\/yr; personnel 18-24% of ops; specialized salaries +30-50%. Leverage 40-50% LTV; global admin +12%.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003e2024-25\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eLab fit-out\u003c\/td\u003e\n\u003ctd\u003e$600-900\/SF\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eAsset price\u003c\/td\u003e\n\u003ctd\u003e$1,000-1,500+\/SF\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eCapex\u003c\/td\u003e\n\u003ctd\u003e$150-250M\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter green\"\u003eR\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003eevenue Streams\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Revenue-Streams-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eBase Rental Income from Leases\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eBase rental income is the main revenue, driven by monthly tenant rents for lab and office space; BioMed Realty reported 2024 same-store rental revenue growth of ~4.5% and portfolio occupancy near 95%, supporting steady cash flows.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Revenue-Streams-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eTriple Net Expense Reimbursements\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eMost of BioMed Realtys leases are triple net (NNN), so tenants reimburse taxes, insurance and common-area maintenance, shielding the landlord from rising operating costs; in 2024 BioMed (now part of Blackstone Real Estate) reported NNN reimbursements offsetting roughly 18% of total property-level expenses on its U.S. portfolio.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Revenue-Streams-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Revenue-Streams-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eDevelopment and Management Fees\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eBioMed Realty earns development and management fees by delivering lab and life-science buildouts for third-party owners and joint ventures, generating non-rental revenue that rose to an estimated $110-130M in 2024, per industry filings. These fees use BioMed's technical expertise with far lower capital outlay than owning assets, diversifying income and helping stabilize cash flow when acquisitions slow.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Revenue-Streams-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eParking and Ancillary Service Fees\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eIn dense urban innovation clusters, BioMed Realty earns notable incremental revenue from parking and ancillary services-parking fees, shared amenities, conferencing centers, and specialized equipment rentals-typically adding 3-6% to portfolio NOI; in 2024 similar campus operators reported ancillary revenue of $1,200-$2,500 per stabilized lab\/office unit annually.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eParking fees: steady cash flow, peak at commute hours\u003c\/li\u003e\n\u003cli\u003eConferencing centers: premium hourly rates, corporate bookings\u003c\/li\u003e\n\u003cli\u003eEquipment rentals: high-margin, short-term contracts\u003c\/li\u003e\n\u003cli\u003eAncillary share of NOI: ~3-6%\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Revenue-Streams-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eStrategic Asset Sale Proceeds\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cpbiomed realty a long-term holder strategically sold of mature assets in realizing double-digit irrs as life-science hub values rose yoy proceeds were redeployed into development pipeline to chase higher-growth labs and campus projects.\u003e\n\u003cp class=\"lst_crct\"\u003e\n\u003c\/p\u003e\u003cli\u003e2024 asset sales: $1.2B\u003c\/li\u003e\n\u003cli\u003eAverage sale IRR: ~12-18%\u003c\/li\u003e\n\u003cli\u003eMarket valuation growth in key hubs (2023-24): ~18% YoY\u003c\/li\u003e\n\u003cli\u003eReinvested into pipeline: $900M (2024)\u003c\/li\u003e\n\n\u003c\/pbiomed\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Revenue-Streams-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eStrong rent growth, 95% occupancy, $1.2B sold, $900M redeployed-15% avg IRR\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eCore revenue: base rents (2024 same-store rent +4.5%, occ ~95%) + NNN reimbursements (~18% of property expenses). Non-rent: development\/management fees ~$120M (2024 est.), ancillary services 3-6% NOI (~$1,200-$2,500\/unit). Asset sales: $1.2B realized (2024), avg sale IRR ~15%, $900M redeployed into development.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003e2024\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eSame-store rent growth\u003c\/td\u003e\n\u003ctd\u003e+4.5%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eOccupancy\u003c\/td\u003e\n\u003ctd\u003e~95%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eNNN reimbursements\u003c\/td\u003e\n\u003ctd\u003e~18% of expenses\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eDev \u0026amp; mgmt fees\u003c\/td\u003e\n\u003ctd\u003e$110-130M (est)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eAncillary NOI\u003c\/td\u003e\n\u003ctd\u003e3-6% (~$1,200-$2,500\/unit)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eAsset sales\u003c\/td\u003e\n\u003ctd\u003e$1.2B\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eAvg sale IRR\u003c\/td\u003e\n\u003ctd\u003e~15%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eReinvested\u003c\/td\u003e\n\u003ctd\u003e$900M\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e","brand":"Value Chain Analysis","offers":[{"title":"Default Title","offer_id":57347184230731,"sku":"biomedrealty-business-model-canvas","price":10.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1049\/6776\/6347\/files\/biomedrealty-canvas-business-model.webp?v=1779127123","url":"https:\/\/valuechainanalysis.com\/products\/biomedrealty-business-model-canvas","provider":"Value Chain Analysis","version":"1.0","type":"link"}